Dissecting the mechanism of signaling-triggered nuclear export of newly synthesized influenza virus ribonucleoprotein complexes. 2020

André Schreiber, and Laurita Boff, and Darisuren Anhlan, and Tim Krischuns, and Linda Brunotte, and Christian Schuberth, and Roland Wedlich-Söldner, and Hannes Drexler, and Stephan Ludwig
Institute of Virology (IVM), Westfaelische Wilhelms Universitaet, Muenster, Nordrhein-Westfalen, 48149, Germany.

Influenza viruses (IV) exploit a variety of signaling pathways. Previous studies showed that the rapidly accelerated fibrosarcoma/mitogen-activated protein kinase/extracellular signal-regulated kinase (Raf/MEK/ERK) pathway is functionally linked to nuclear export of viral ribonucleoprotein (vRNP) complexes, suggesting that vRNP export is a signaling-induced event. However, the underlying mechanism remained completely enigmatic. Here we have dissected the unknown molecular steps of signaling-driven vRNP export. We identified kinases RSK1/2 as downstream targets of virus-activated ERK signaling. While RSK2 displays an antiviral role, we demonstrate a virus-supportive function of RSK1, migrating to the nucleus to phosphorylate nucleoprotein (NP), the major constituent of vRNPs. This drives association with viral matrix protein 1 (M1) at the chromatin, important for vRNP export. Inhibition or knockdown of MEK, ERK or RSK1 caused impaired vRNP export and reduced progeny virus titers. This work not only expedites the development of anti-influenza strategies, but in addition demonstrates converse actions of different RSK isoforms.

UI MeSH Term Description Entries
D007251 Influenza, Human An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. Grippe,Human Flu,Human Influenza,Influenza in Humans,Influenza,Flu, Human,Human Influenzas,Influenza in Human,Influenzas,Influenzas, Human
D009980 Influenza A virus The type species of the genus ALPHAINFLUENZAVIRUS that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is usually by aerosol (human and most non-aquatic hosts) or waterborne (ducks). Infected birds shed the virus in their saliva, nasal secretions, and feces. Alphainfluenzavirus influenzae,Avian Orthomyxovirus Type A,FLUAV,Fowl Plague Virus,Human Influenza A Virus,Influenza Virus Type A,Influenza Viruses Type A,Myxovirus influenzae-A hominis,Myxovirus influenzae-A suis,Myxovirus pestis galli,Orthomyxovirus Type A,Orthomyxovirus Type A, Avian,Orthomyxovirus Type A, Human,Orthomyxovirus Type A, Porcine,Pestis galli Myxovirus,Fowl Plague Viruses,Influenza A viruses,Myxovirus influenzae A hominis,Myxovirus influenzae A suis,Myxovirus, Pestis galli,Myxoviruses, Pestis galli,Pestis galli Myxoviruses,Plague Virus, Fowl,Virus, Fowl Plague
D002467 Cell Nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Cell Nuclei,Nuclei, Cell,Nucleus, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012261 Ribonucleoproteins Complexes of RNA-binding proteins with ribonucleic acids (RNA). Ribonucleoprotein
D014763 Viral Matrix Proteins Proteins associated with the inner surface of the lipid bilayer of the viral envelope. These proteins have been implicated in control of viral transcription and may possibly serve as the "glue" that binds the nucleocapsid to the appropriate membrane site during viral budding from the host cell. Membrane Proteins, Viral,Viral M Proteins,Viral M Protein,Viral Membrane Proteins
D049790 Nuclear Export Signals Specific amino acid sequences present in the primary amino acid sequence of proteins which mediate their export from the CELL NUCLEUS. They are rich in hydrophobic residues, such as LEUCINE and ISOLEUCINE. NES Peptide,Nuclear Export Signal,Nuclear Export Signal Peptide,Export Signal, Nuclear,Export Signals, Nuclear,NES Peptides,Peptide, NES,Peptides, NES,Signal, Nuclear Export,Signals, Nuclear Export
D020935 MAP Kinase Signaling System An intracellular signaling system involving the mitogen-activated protein kinase cascades (three-membered protein kinase cascades). Various upstream activators, which act in response to extracellular stimuli, trigger the cascades by activating the first member of a cascade, MAP KINASE KINASE KINASES; (MAPKKKs). Activated MAPKKKs phosphorylate MITOGEN-ACTIVATED PROTEIN KINASE KINASES which in turn phosphorylate the MITOGEN-ACTIVATED PROTEIN KINASES; (MAPKs). The MAPKs then act on various downstream targets to affect gene expression. In mammals, there are several distinct MAP kinase pathways including the ERK (extracellular signal-regulated kinase) pathway, the SAPK/JNK (stress-activated protein kinase/c-jun kinase) pathway, and the p38 kinase pathway. There is some sharing of components among the pathways depending on which stimulus originates activation of the cascade. MAP Kinase Cascade,MAP Kinase Module,MAP Kinase Signaling Cascade,MAP Kinase Signaling Pathway,MAP Kinase Signaling Pathways,ERK Pathway,ERK Signal Tranduction Pathway,ERK1 and ERK2 Pathway,ERK1-2 Pathway,JNK Pathway,JNK Signaling Pathway,MAP Kinase Modules,MAP Kinase Signaling Cascades,MEK-ERK Pathway,p38 Kinase Pathway,p38 Kinase Signaling Pathway,Cascade, MAP Kinase,ERK Pathways,ERK1 2 Pathway,ERK1-2 Pathways,JNK Pathways,JNK Signaling Pathways,Kinase Cascade, MAP,Kinase Pathway, p38,Kinase Pathways, p38,MAP Kinase Cascades,MEK ERK Pathway,MEK-ERK Pathways,Module, MAP Kinase,Pathway, ERK,Pathway, ERK1-2,Pathway, JNK,Pathway, JNK Signaling,Pathway, MEK-ERK,Pathway, p38 Kinase,Pathways, ERK,Pathways, ERK1-2,Pathways, JNK,Pathways, JNK Signaling,Pathways, MEK-ERK,Pathways, p38 Kinase,Signaling Pathway, JNK,Signaling Pathways, JNK,p38 Kinase Pathways
D021581 Active Transport, Cell Nucleus Gated transport mechanisms by which proteins or RNA are moved across the NUCLEAR MEMBRANE. Nuclear Export,Nuclear Import,Nuclear Transport,Nucleocytoplasmic Transport,Nucleo-cytoplasmic Transport,Export, Nuclear,Import, Nuclear,Nucleo cytoplasmic Transport,Transport, Nuclear,Transport, Nucleo-cytoplasmic,Transport, Nucleocytoplasmic,Transports, Nucleo-cytoplasmic
D038744 Ribosomal Protein S6 Kinases, 90-kDa A family of ribosomal protein S6 kinases that are structurally distinguished from RIBOSOMAL PROTEIN S6 KINASES, 70-KDA by their apparent molecular size and the fact they contain two functional kinase domains. Although considered RIBOSOMAL PROTEIN S6 KINASES, members of this family are activated via the MAP KINASE SIGNALING SYSTEM and have been shown to act on a diverse array of substrates that are involved in cellular regulation such as RIBOSOMAL PROTEIN S6 and CAMP RESPONSE ELEMENT-BINDING PROTEIN. MAP-Kinase-Activated Kinase 1,MAP-Kinase-Activated Protein Kinase 1,MAPKAP Kinase-1,MAPKAP-K1,MAPKAPK1,Ribosomal Protein S6 Kinase, 90-kDa,p90 Ribosomal S6 Kinase,p90(rsk),pp90(rsk),MAP Kinase Activated Kinase 1,MAP Kinase Activated Protein Kinase 1,MAPKAP Kinase 1,Ribosomal Protein S6 Kinase, 90 kDa,Ribosomal Protein S6 Kinases, 90 kDa

Related Publications

André Schreiber, and Laurita Boff, and Darisuren Anhlan, and Tim Krischuns, and Linda Brunotte, and Christian Schuberth, and Roland Wedlich-Söldner, and Hannes Drexler, and Stephan Ludwig
April 2022, Analytical chemistry,
André Schreiber, and Laurita Boff, and Darisuren Anhlan, and Tim Krischuns, and Linda Brunotte, and Christian Schuberth, and Roland Wedlich-Söldner, and Hannes Drexler, and Stephan Ludwig
September 2001, Virus research,
André Schreiber, and Laurita Boff, and Darisuren Anhlan, and Tim Krischuns, and Linda Brunotte, and Christian Schuberth, and Roland Wedlich-Söldner, and Hannes Drexler, and Stephan Ludwig
June 2015, Journal of virology,
André Schreiber, and Laurita Boff, and Darisuren Anhlan, and Tim Krischuns, and Linda Brunotte, and Christian Schuberth, and Roland Wedlich-Söldner, and Hannes Drexler, and Stephan Ludwig
March 2007, Virus research,
André Schreiber, and Laurita Boff, and Darisuren Anhlan, and Tim Krischuns, and Linda Brunotte, and Christian Schuberth, and Roland Wedlich-Söldner, and Hannes Drexler, and Stephan Ludwig
December 2018, Molecules (Basel, Switzerland),
André Schreiber, and Laurita Boff, and Darisuren Anhlan, and Tim Krischuns, and Linda Brunotte, and Christian Schuberth, and Roland Wedlich-Söldner, and Hannes Drexler, and Stephan Ludwig
February 2015, Seikagaku. The Journal of Japanese Biochemical Society,
André Schreiber, and Laurita Boff, and Darisuren Anhlan, and Tim Krischuns, and Linda Brunotte, and Christian Schuberth, and Roland Wedlich-Söldner, and Hannes Drexler, and Stephan Ludwig
September 2011, PLoS pathogens,
André Schreiber, and Laurita Boff, and Darisuren Anhlan, and Tim Krischuns, and Linda Brunotte, and Christian Schuberth, and Roland Wedlich-Söldner, and Hannes Drexler, and Stephan Ludwig
October 2003, Archives of virology,
André Schreiber, and Laurita Boff, and Darisuren Anhlan, and Tim Krischuns, and Linda Brunotte, and Christian Schuberth, and Roland Wedlich-Söldner, and Hannes Drexler, and Stephan Ludwig
January 2000, Journal of virology,
André Schreiber, and Laurita Boff, and Darisuren Anhlan, and Tim Krischuns, and Linda Brunotte, and Christian Schuberth, and Roland Wedlich-Söldner, and Hannes Drexler, and Stephan Ludwig
September 2001, Virology,
Copied contents to your clipboard!